首页 | 本学科首页   官方微博 | 高级检索  
     

慢性肾衰血透患者骨代谢的评估
引用本文:章俊 曾熙兰. 慢性肾衰血透患者骨代谢的评估[J]. 标记免疫分析与临床, 1997, 4(3): 139-142
作者姓名:章俊 曾熙兰
作者单位:[1]第一军医大学珠江医院 [2]中山医科大学放免中心
摘    要:用IRMA、RRA和RIA等对24例维持血透患者(MHD)测定其血甲状旁腺激素、PTH(1 ̄84)、25(OH)D3、1,25(OH)2D3、BGP、血钙和磷的变化,以探讨它们之间的关系和评估患者骨代谢的状况。MHD患者PTH和BGP升高,透析后则降低;25(OH)D3和1,25(OH)2D3降低,透析对其无明显影响;PTH与25(OH)D3、1,25(OH)2D3呈负相关,P分别小于0.05和0

关 键 词:肾功能衰竭 慢性 血液透析 骨代谢

Evaluation of Bone Metabolism in Patients with Chronic Renal Failure Maintained by Hemodialysis
Zhang Jun, Zeng Xilan, Zeng Li. Evaluation of Bone Metabolism in Patients with Chronic Renal Failure Maintained by Hemodialysis[J]. Labeled Immunoassays and Clinical Medicine, 1997, 4(3): 139-142
Authors:Zhang Jun   Zeng Xilan   Zeng Li
Abstract:The changes of PTH, 25(OH)D3, 1, 25(OH)2D3, BGP, Ca and P levels in the blood of 24 hemodialysis patients and their relationship were investigated by IRMA, RRA and RIA. PTH and BGP were increased in HD patients and decreased after hemodialysis. 25(OH)D3and 1, 25 (OH)2D3 were decreased in patients, but their levels were not changed further after hemodialysis. PTH had both a negative correlation with 25(OH)D3 (r=-0. 391, P < 0. 05) or 1, 25(OH)2D3(r=-0. 493, P< 0. 01), and a positive correlation with BGP (r=0. 517, P<0.01) in HD patients. PTH hypersecretion is a main factor inducing bone metabolism disturbance and bone turnover rate is increased in these patients.
Keywords:Renal failure   chronic Hemodialysis Parathyroid hormone Osteocalcin Vitamin D
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号